Prostate Cancer Clinical Trials
Find clinical trials for prostate cancer. Search for prostate cancer clinical trials in different cities and states across the United States.
Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain ReliefStereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief
Sponsor:
Hamilton Health Sciences Corporation
Location:
Code:
NCT04177056
Conditions
Bone Metastases
Prostate Cancer
Breast Cancer
Renal Cell Carcinoma
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SBRT
BMS-986365 vs. Investigator's ChoiceA Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Sponsor:
Celgene
Location:
Code:
NCT06764485
Conditions
Metastatic Castration-resistant Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMS-986365
Enzalutamide
Abiraterone
Docetaxel
Predinsone/Prednisolone
sEphB4-HSA&PembrolizumabMulticohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors
Sponsor:
University of Southern California
Location:
Code:
NCT02717156
Conditions
Stage IV Bladder Urothelial Carcinoma
Prostate Cancer
Urothelial Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Computed Tomography
Laboratory Biomarker Analysis
Pembrolizumab
Positron Emission Tomography
Recombinant EphB4-HSA Fusion Protein
Observational StudyMicroendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
Sponsor:
Ryan J. Halter
Location:
Code:
NCT06039085
Conditions
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
custom device to demonstrate a significant difference in electrical impedance signatures
Fluoro-2-Deoxy-D-Glucose & Dihydro-Testosterone[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Location:
Code:
NCT00588185
Conditions
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone
TT-10 & TT-4TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors
Sponsor:
Portage Biotech
Location:
Code:
NCT04969315
Conditions
Renal Cell Cancer
Castrate Resistant Prostate Cancer
Non Small Cell Lung Cancer
Head and Neck Squamous Cell Carcinoma
Colorectal Cancer (CRC)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TT-10
TT-4
Cabozantinib & NivolumabStudy of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
Sponsor:
Rana McKay, MD
Location:
Code:
NCT05502315
Conditions
Castration-resistant Prostate Cancer
Metastatic Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cabozantinib
Nivolumab
Moderate & Ultra-hypofractionatedPost-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
Sponsor:
University of Michigan Rogel Cancer Center
Location:
Code:
NCT05038332
Conditions
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ultra-hypofractionated radiation therapy
Moderately Hypo-fractionated Radiation Therapy
WATER IVWATER IV Prostate Cancer
Sponsor:
PROCEPT BioRobotics
Location:
Code:
NCT06651632
Conditions
Localized Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 45+
Healthy Volunteers: Not accepted
Interventions
Aquablation Therapy
Radical Prostatectomy